Speaking at BIO 2026, Kasper Øland, Samsung Biologics' vice president of sales execution, emphasizes how complex molecules now exceed 55% of the company’s pipeline as biotechs demand faster, more flexible CDMO partnerships.
Kasper Øland
Advertisement
Kasper Øland is vice president of sales execution for the CDO Services division of Samsung Biologics.
Articles by Kasper Øland
Advertisement
Latest Updated Articles
Advertisement
Advertisement